Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
19.64B
Market cap19.64B
Price-Earnings ratio
20.92
Price-Earnings ratio20.92
Dividend yield
1.77%
Dividend yield1.77%
Average volume
1.04M
Average volume1.04M
High today
$178.98
High today$178.98
Low today
$175.67
Low today$175.67
Open price
$178.39
Open price$178.39
Volume
807.05K
Volume807.05K
52 Week high
$197.55
52 Week high$197.55
52 Week low
$148.70
52 Week low$148.70

Stock Snapshot

As of today, Quest Diagnostics(DGX) shares are valued at $176.51. The company's market cap stands at 19.64B, with a P/E ratio of 20.92 and a dividend yield of 1.8%.

On 2025-11-07, Quest Diagnostics(DGX) stock moved within a range of $175.67 to $178.98. With shares now at $176.51, the stock is trading +0.5% above its intraday low and -1.4% below the session's peak.

Trading volume for Quest Diagnostics(DGX) stock has reached 807.05K, versus its average volume of 1.04M.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $148.70.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $148.70.

DGX News

Simply Wall St 6d
The Bull Case For Quest Diagnostics Could Change Following New Alzheimer's Blood Test Validation Study

Quest Diagnostics recently announced that two of its blood tests, each using multiple biomarkers, showed high accuracy in identifying Alzheimer's disease pathol...

The Bull Case For Quest Diagnostics Could Change Following New Alzheimer's Blood Test Validation Study

Analyst ratings

59%

of 22 ratings
Buy
40.9%
Hold
59.1%
Sell
0%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.